Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
45
OMF Quote, Financials, Valuation and Earnings
Last price:
$51.91
Seasonality move
:
4.13%
Day range:
$51.21 - $52.16
52-week range:
$41.70 - $57.97
Dividend yield:
7.93%
P/E ratio:
11.37x
P/S ratio:
1.40x
P/B ratio:
1.93x
Volume:
510.7K
Avg. volume:
893.6K
1-year change:
5.98%
Market cap:
$6.2B
Revenue:
$4.3B
EPS (TTM):
$4.57
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $4B | $4.2B | $4.3B | |
| Revenue Growth (YoY) | 10.28% | 5.23% | 3.33% | 4.04% | 1.93% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $993M | $998M | $1B | $994M | $1B | |
| Other Inc / (Exp) | $95M | $75M | $65M | $61M | $116M | |
| Operating Expenses | $909M | $959M | $937M | $967M | $1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1B | $977M | $1.7B | $1.2B | $840M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $243M | $247M | $427M | $283M | $199M | |
| Net Income to Company | $855M | $730M | $1.3B | $872M | $641M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $855M | $730M | $1.3B | $872M | $641M | |
| Basic EPS (Cont. Ops) | $6.28 | $5.42 | $9.91 | $7.02 | $5.33 | |
| Diluted EPS (Cont. Ops) | $6.27 | $5.41 | $9.88 | $7.01 | $5.32 | |
| Weighted Average Basic Share | $136.1M | $134.7M | $132.7M | $124.2M | $120.4M | |
| Weighted Average Diluted Share | $136.3M | $134.9M | $133.1M | $124.4M | $120.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.1B | $2B | $2.7B | $2B | $1.9B | |
| Revenue (Reported) | $3.7B | $3.9B | $4B | $4.2B | $4.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.1B | $2B | $2.7B | $2B | $1.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $973M | $1B | $1.1B | $1.1B | $1.2B | |
| Revenue Growth (YoY) | -0.61% | 6.06% | 3% | 2.07% | 7.28% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $229M | $274M | $247M | $265M | $263M | |
| Other Inc / (Exp) | $17M | $14M | $16M | $32M | $24M | |
| Operating Expenses | $188M | $272M | $249M | $265M | $262M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $341M | $376M | $246M | $246M | $207M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $91M | $88M | $61M | $52M | $50M | |
| Net Income to Company | $250M | $288M | $185M | $194M | $158M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $250M | $288M | $185M | $194M | $157M | |
| Basic EPS (Cont. Ops) | $1.86 | $2.17 | $1.50 | $1.61 | $1.32 | |
| Diluted EPS (Cont. Ops) | $1.86 | $2.17 | $1.49 | $1.61 | $1.31 | |
| Weighted Average Basic Share | $134.3M | $132.5M | $123.4M | $120.4M | $119.7M | |
| Weighted Average Diluted Share | $134.5M | $132.9M | $123.6M | $120.8M | $120.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $596M | $613M | $469M | $513M | $508M | |
| Revenue (Reported) | $973M | $1B | $1.1B | $1.1B | $1.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $596M | $613M | $469M | $513M | $508M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.8B | $4B | $4.2B | $4.2B | $4.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $967M | $1B | $1B | $1B | |
| Other Inc / (Exp) | $79M | $67M | $58M | $105M | $119M | |
| Operating Expenses | $923M | $933M | $968M | $1B | $1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $845M | $1.9B | $1.3B | $851M | $724M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $213M | $450M | $319M | $199M | $176M | |
| Net Income to Company | $632M | $1.4B | $959M | $652M | $548M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $632M | $1.4B | $959M | $652M | $548M | |
| Basic EPS (Cont. Ops) | $4.68 | $10.52 | $7.60 | $5.43 | $4.58 | |
| Diluted EPS (Cont. Ops) | $4.67 | $10.50 | $7.56 | $5.42 | $4.57 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.9B | $2.8B | $2.2B | $1.8B | $1.9B | |
| Revenue (Reported) | $3.8B | $4B | $4.2B | $4.2B | $4.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.9B | $2.8B | $2.2B | $1.8B | $1.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3B | $3.1B | $3.2B | $3.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $770M | $738M | $741M | $787M | $790M | |
| Other Inc / (Exp) | $55M | $48M | $40M | $84M | $86M | |
| Operating Expenses | $729M | $688M | $715M | $787M | $777M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $502M | $1.4B | $923M | $619M | $503M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $131M | $334M | $227M | $143M | $120M | |
| Net Income to Company | $371M | $1.1B | $696M | $476M | $383M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $371M | $1.1B | $696M | $476M | $383M | |
| Basic EPS (Cont. Ops) | $2.76 | $7.85 | $5.55 | $3.94 | $3.20 | |
| Diluted EPS (Cont. Ops) | $2.76 | $7.83 | $5.54 | $3.94 | $3.19 | |
| Weighted Average Basic Share | $404.5M | $401.1M | $375M | $361.7M | $359.3M | |
| Weighted Average Diluted Share | $405M | $402.4M | $375.7M | $362.4M | $360.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.3B | $2.1B | $1.6B | $1.4B | $1.4B | |
| Revenue (Reported) | $2.9B | $3B | $3.1B | $3.2B | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.3B | $2.1B | $1.6B | $1.4B | $1.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $2.3B | $541M | $498M | $1B | |
| Short Term Investments | $1.8B | $1.8B | $1.9B | $1.7B | $458M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3B | $4.1B | $2.4B | $2.2B | $1.5B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $1.9B | $1.9B | $2B | $1.8B | $1.7B | |
| Goodwill | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Other Intangibles | $343M | $306M | $274M | $261M | $260M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $22.8B | $22.5B | $22.1B | $22.5B | $24.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $17.2B | $17.8B | $17.8B | $18.3B | $19.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.5B | $19B | $19B | $19.5B | $21.1B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $4.3B | $3.4B | $3.1B | $3B | $3.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.3B | $3.4B | $3.1B | $3B | $3.2B | |
| Total Liabilities and Equity | $22.8B | $22.5B | $22.1B | $22.5B | $24.3B | |
| Cash and Short Terms | $3B | $4.1B | $2.4B | $2.2B | $1.5B | |
| Total Debt | $17.2B | $17.8B | $17.8B | $18.3B | $19.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.9B | $821M | $536M | $1B | $311M | |
| Short Term Investments | $128M | $462M | $486M | $439M | $435M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.1B | $1.3B | $1B | $1.5B | $746M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $1.9B | $2B | $1.7B | $1.6B | $1.6B | |
| Goodwill | $1.4B | $1.4B | $1.4B | $1.4B | $1.5B | |
| Other Intangibles | $315M | $278M | $272M | $260M | $288M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $21.9B | $22B | $22.3B | $24.1B | $25.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $176M | |
| Long-Term Debt | $17.5B | $17.7B | $18.2B | $19.9B | $21B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.7B | $18.8B | $19.3B | $21B | $22.4B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.1B | $3.1B | $3B | $3.1B | $3.2B | |
| Total Liabilities and Equity | $21.9B | $22B | $22.3B | $24.1B | $25.6B | |
| Cash and Short Terms | $2.1B | $1.3B | $1B | $1.5B | $746M | |
| Total Debt | $17.5B | $17.7B | $18.2B | $19.9B | $21.1B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $855M | $730M | $1.3B | $872M | $641M | |
| Depreciation & Amoritzation | $271M | $264M | $264M | $262M | $257M | |
| Stock-Based Compensation | $13M | $17M | $23M | $31M | $36M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $2.2B | $2.2B | $2.4B | $2.5B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.4B | -$751M | -$2.1B | -$2.1B | -$2.9B | |
| Dividends Paid (Ex Special Dividend) | -$408M | -$806M | -$1.3B | -$480M | -$487M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.9B | $7.3B | $3.8B | $5.6B | $4.8B | |
| Long-Term Debt Repaid | -$4B | -$6.8B | -$3.9B | -$5.1B | -$3.3B | |
| Repurchase of Common Stock | -- | -$45M | -$368M | -$303M | -$65M | |
| Other Financing Activities | -$5M | -$6M | -$6M | -$14M | -$10M | |
| Cash From Financing | $1.5B | -$370M | -$1.8B | -$326M | $932M | |
| Beginning Cash (CF) | $1.2B | $1.6B | $2.7B | $1B | $959M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $454M | $1.1B | -$1.7B | -$58M | $589M | |
| Ending Cash (CF) | $1.6B | $2.7B | $1B | $959M | $1.5B | |
| Levered Free Cash Flow | $2.4B | $2.2B | $2.2B | $2.4B | $2.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $250M | $288M | $185M | $194M | $158M | |
| Depreciation & Amoritzation | $66M | $70M | $63M | $66M | $71M | |
| Stock-Based Compensation | $3M | $5M | $8M | $6M | $7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $425M | $509M | $545M | $596M | $677M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$363M | -$869M | -$695M | -$892M | -$1B | |
| Dividends Paid (Ex Special Dividend) | -$314M | -$557M | -$118M | -$121M | -$126M | |
| Special Dividend Paid | -- | $3.5M | -- | -- | -- | |
| Long-Term Debt Issued | $989M | $590M | $1.9B | $1.4B | $1.3B | |
| Long-Term Debt Repaid | -$1.5B | -$545M | -$1.6B | -$743M | -$860M | |
| Repurchase of Common Stock | -- | -$141M | -$43M | -$11M | -$19M | |
| Other Financing Activities | -- | -$1M | -$2M | -$2M | -$2M | |
| Cash From Financing | -$848M | -$654M | $109M | $513M | $303M | |
| Beginning Cash (CF) | $3.2B | $2.3B | $1.1B | $1.6B | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$786M | -$1B | -$41M | $217M | -$27M | |
| Ending Cash (CF) | $2.4B | $1.3B | $1B | $1.8B | $1.3B | |
| Levered Free Cash Flow | $425M | $509M | $545M | $596M | $677M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $632M | $1.4B | $959M | $652M | $548M | |
| Depreciation & Amoritzation | $264M | $265M | $255M | $265M | $273M | |
| Stock-Based Compensation | $16M | $20M | $34M | $31M | $32M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $2.2B | $2.3B | $2.5B | $2.6B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$64M | |
| Cash From Investing | -$1.2B | -$2B | -$2.1B | -$2.8B | -$2.9B | |
| Dividends Paid (Ex Special Dividend) | -$779M | -$1.2B | -$453M | -$482M | -$494M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.2B | -- | $6.1B | $4.9B | -- | |
| Long-Term Debt Repaid | -$6.8B | -$3B | -$5.6B | -$3.3B | -$3.9B | |
| Repurchase of Common Stock | -$45M | -$176M | -$439M | -$101M | -$52M | |
| Other Financing Activities | -$6M | -$6M | -$14M | -$10M | -$10M | |
| Cash From Financing | -$418M | -$1.4B | -$451M | $1B | -$177M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $614M | -$1.2B | -$261M | $751M | -$500M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.3B | $2.2B | $2.3B | $2.5B | $2.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $371M | $1.1B | $696M | $476M | $383M | |
| Depreciation & Amoritzation | $196M | $197M | $188M | $191M | $207M | |
| Stock-Based Compensation | $13M | $16M | $27M | $27M | $23M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$64M | |
| Cash From Investing | -$257M | -$1.5B | -$1.5B | -$2.2B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$745M | -$1.2B | -$364M | -$366M | -$373M | |
| Special Dividend Paid | $2.5M | $3.5M | -- | -- | -- | |
| Long-Term Debt Issued | $6.4B | $2.2B | $4.5B | $3.7B | $3.2B | |
| Long-Term Debt Repaid | -$6.2B | -$2.4B | -$4.1B | -$2.2B | -$2.8B | |
| Repurchase of Common Stock | -$45M | -$176M | -$247M | -$45M | -$32M | |
| Other Financing Activities | -$6M | -$6M | -$14M | -$10M | -$10M | |
| Cash From Financing | -$563M | -$1.6B | -$224M | $1.1B | $13M | |
| Beginning Cash (CF) | $9.6B | $6.9B | $3.2B | $3.6B | $4.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $809M | -$1.4B | $2M | $811M | -$278M | |
| Ending Cash (CF) | $10.4B | $5.4B | $3.3B | $4.4B | $4B | |
| Levered Free Cash Flow | $1.6B | $1.6B | $1.7B | $1.8B | $1.9B | |
Get OMF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OMF
Sector
P/E ratio
11.37x
12.02x
PEG ratio
--
0.36x
P/B ratio
1.93x
1.05x
Price / LTM sales
1.40x
2.55x
Growth Metrics
OMF
Sector
Revenue growth
7.28%
6.08%
Earnings growth
-18.63%
6.45%
Revenue (5-year growth)
4.92%
5.85%
Earnings forecast
$1.14
$0.56
Profitability
OMF
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
2.35%
5.27%
Return on assets
2.23%
0.98%
Return on equity
17.27%
9.43%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Jan
29
Balance Sheet
OMF
Sector
Total cash
$746M
$617M
Short term investments
$458M
$408.4M
Total assets
$24.3B
$4.5B
Long term debt
$21.1B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is down 8.7% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 9.77% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is up 7.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
